Acrivon Therapeutics (ACRV) Institutional Ownership → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free ACRV Stock Alerts $8.89 +0.33 (+3.86%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Acrivon Therapeutics (NASDAQ:ACRV)CurrentInstitutional OwnershipPercentage71.62%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$920.10KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$781.28K Get ACRV Insider Trade Alerts Want to know when executives and insiders are buying or selling Acrivon Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACRV Institutional Buying and Selling by Quarter Ad Monument Traders AllianceMake this ONE trade on Tuesday at 2 p.m. EST!Every time the U.S. Government releases jobs, inflation, GDP and other Economic Reports… Use The JOLTS Loophole to target up to 253%... 327%... Even 383% Overnight Profits!Discover The Secret Loophole BEFORE Tuesday! Acrivon Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024 Baker BROS. Advisors LP52,885$378K0.0%N/A0.234% 5/14/2024 American International Group Inc.6,016$43K0.0%+39.2%0.027% 5/10/2024 Vanguard Group Inc.507,185$3.63M0.0%+6.6%2.241% 1/5/2024 Exchange Traded Concepts LLC13,289$65K0.0%+34.0%0.060% 11/13/2023 Federated Hermes Inc.226,375$2.16M0.0%-25.6%1.020% 9/21/2023 Barclays PLC14,263$184K0.0%-16.0%0.065% 8/10/2023 AAF Wealth Management LLC10,678$138K0.1%N/A0.049% 7/20/2023 Exchange Traded Concepts LLC11,709$152K0.0%N/A0.053% 5/8/2023 Federated Hermes Inc.613,625$7.79M0.0%-25.5%2.798% 2/16/2023HealthCor Management L.P.284,201$3.27M3.0%N/A1.360% 2/14/2023 RA Capital Management L.P.4,810,508$55.42M1.1%N/A23.028% 2/13/2023 Sands Capital Ventures LLC1,652,605$19.04M5.2%N/A7.913% 2/10/2023 NEA Management Company LLC481,677$4.44M0.2%N/A2.306% 2/1/2023 Bank of Montreal Can42,444$545K0.0%N/A0.203% (Data available from 1/1/2016 forward) ACRV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACRV shares? During the previous two years, 12 institutional investors and hedge funds held shares of Acrivon Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($55.42M), Sands Capital Ventures LLC ($19.04M), NEA Management Company LLC ($4.44M), Vanguard Group Inc. ($3.63M), HealthCor Management L.P. ($3.27M), Federated Hermes Inc. ($2.16M), and Bank of Montreal Can ($545K).Learn more on ACRV's institutional investors. What percentage of Acrivon Therapeutics stock is owned by institutional investors? 71.62% of Acrivon Therapeutics stock is owned by institutional investors. Learn more on ACRV's institutional investor holdings. Which institutional investors have been buying Acrivon Therapeutics stock? Of the 10 institutional investors that purchased Acrivon Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($4.81M), Sands Capital Ventures LLC ($1.65M), NEA Management Company LLC ($481.68K), HealthCor Management L.P. ($284.20K), Baker BROS. Advisors LP ($52.89K), Bank of Montreal Can ($42.44K), and Vanguard Group Inc. ($31.21K). How much institutional buying is happening at Acrivon Therapeutics? Institutional investors have bought a total of 7,382,980 shares in the last 24 months. This purchase volume represents approximately $84.69M in transactions. Which Acrivon Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Acrivon Therapeutics stock in the last 24 months: Federated Hermes Inc. ($287.71K), and Barclays PLC ($2.72K). How much institutional selling is happening at Acrivon Therapeutics? Institutional investors have sold a total of 290,431 shares in the last 24 months. This volume of shares sold represents approximately $3.44M in transactions. Related Companies: Organigram Institutional Ownership Inventiva Institutional Ownership Telomir Pharmaceuticals Institutional Ownership Atossa Therapeutics Institutional Ownership Lifecore Biomedical Institutional Ownership Incannex Healthcare Institutional Ownership Zevra Therapeutics Institutional Ownership Galectin Therapeutics Institutional Ownership Greenwich LifeSciences Institutional Ownership Trevi Therapeutics Institutional Ownership This page (NASDAQ:ACRV) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acrivon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
